106869-48-1

Basic information

• Product Name: 2-Pyrrolidinone, 4-phenyl-1-(trimethylsilyl)-
• CAS NO: 106869-48-1
• Molecular Formula: C13H19NOSi
• Molecular Weight: 233.385
• Mol File: 106869-48-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-Pyrrolidinone, 4-phenyl-1-(trimethylsilyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyrrolidinone, 4-phenyl-1-(trimethylsilyl)-(106869-48-1)
• EPA Substance Registry System: 2-Pyrrolidinone, 4-phenyl-1-(trimethylsilyl)-(106869-48-1)

Safety Data

• Hazardous Substances Data: 106869-48-1(Hazardous Substances Data)

Upstream product

• 3060-41-1 (±)-3-carboxy-2-phenylpropan-1-aminium chloride 
• 999-97-3 1,1,1,3,3,3-hexamethyl-disilazane 
• 1198-97-6 4-phenylpyrrolidin-2-one 
• 1450-14-2 1,1,1,2,2,2-hexamethyldisilane 

Downstream Products

• 124663-67-8 1-(Bromo-dimethyl-silanylmethyl)-4-phenyl-pyrrolidin-2-one 
• 75-77-4 chloro-trimethyl-silane 
• 139885-35-1 N,N-Diethyl-2-(2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide 
• 124663-76-9 C₁₅H₁₈F₃NO₃Si 
• 124663-72-5 C₁₅H₂₁NO₃Si 
• 77472-70-9 (RS)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide 
• 67118-34-7 2-(2-oxo-4-phenylpyrrolidin-1-yl)acetic acid 
• 67118-22-3 N-(2-Oxo-4-phenyl-1-pyrrolidineacetyl)-glycine ethyl ester 
• 67118-05-2 2-(2-oxo-4-phenyl-1-pyrrolidineacetamido)-acetamide 
• 208844-59-1 4-[2-(2-oxo-4-phenyl-pyrrolidin-1-yl)-acetylamino]-butyric acid ethyl ester 
• 208844-57-9 3-[2-(2-oxo-4-phenyl-pyrrolidin-1-yl)-acetylamino]-propionic acid ethyl ester 
• 208844-55-7 2-[2-(2-oxo-4-phenyl-pyrrolidin-1-yl)-acetylamino]-propionic acid ethyl ester 

Relevant articles and documents

SYNTHESIS OF N-(SILATRANYLMETHYL)-SUBSTITUTED LACTAMS AND CARBOXYLIC ACID AMIDES

The general approach proposed for the synthesis of N-silatranylmethyl derivatives of lactams and carboxylic acid amides is based on the silyl variant of the akylation reaction.The treatment of N-trimethylsilyl-substituted lactams and carboxylic acid amides yielded N-trialkoxysilylmethyl lactam and amide derivatives.These were converted into the corresponding silatranes by the usual procedure (treating with triethanolamine in the presence of KOH).